A Study to Evaluate the Efficacy and Safety of TNX-1900 in Patients With Chronic Migraine
Study sponsor: Tonix Pharmaceuticals, Inc.
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2023-10-08Actual
Enrollment · participants88Actual
Source updated2025-02-25Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.